Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults

Key Points Clinically actionable thrombotic microangiopathy (CA-TMA) occurring in the absence of aGVHD occurs earlier than day 100. aGVHD is a key and consistent risk factor for late-onset CA-TMA.

[1]  Stephanie J. Lee,et al.  Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-Term Survivors , 2020 .

[2]  R. Varadhan,et al.  Thrombotic Microangiopathy After Post-Transplantation Cyclophosphamide-Based GVHD Prophylaxis. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  S. Davies,et al.  Endothelial injury, F-actin and vitamin D binding protein after hematopoietic stem cell transplant and association with clinical outcomes , 2020, Haematologica.

[4]  M. Aljurf,et al.  Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy , 2020, British journal of haematology.

[5]  T. Deloughery,et al.  Biopsy‐proven thrombotic microangiopathy without schistocytosis on peripheral blood smear: A cautionary tale , 2019, American journal of hematology.

[6]  M. Sorror,et al.  Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  Y. Efebera,et al.  Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD. , 2018, Blood advances.

[8]  Z. Prohászka,et al.  Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  G. Vercellotti,et al.  Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402 , 2017, Bone Marrow Transplantation.

[10]  K. Friedman,et al.  Impact of treatment and outcomes for patients with posttransplant drug‐associated thrombotic microangiopathy , 2017, Transfusion.

[11]  Depei Wu,et al.  Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation , 2017, Annals of Hematology.

[12]  S. Davies,et al.  ST2 and Endothelial Injury as a Link between GVHD and Microangiopathy. , 2017, The New England journal of medicine.

[13]  R. Brodsky,et al.  Transplant-associated thrombotic microangiopathy: opening Pandora’s box , 2017, Bone Marrow Transplantation.

[14]  M. MacMillan,et al.  A risk-adapted approach to acute GVHD treatment: are we there yet? , 2016, Bone Marrow Transplantation.

[15]  K. Myers,et al.  Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  B. Storer,et al.  Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment. , 2015, Blood.

[17]  K. van Besien,et al.  Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. , 2014, Clinical advances in hematology & oncology : H&O.

[18]  J. Khoury,et al.  Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. , 2014, Blood.

[19]  Ranjit S. Chima,et al.  Pulmonary hypertension after hematopoietic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  T. A. Sivakumaran,et al.  Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. , 2013, Blood.

[21]  T. Braun,et al.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. , 2013, The New England journal of medicine.

[22]  N. Toda.  Age-related changes in endothelial function and blood flow regulation. , 2012, Pharmacology & therapeutics.

[23]  A. Schmaier,et al.  Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation , 2012, Drugs.

[24]  Douglas R Seals,et al.  Aging and vascular endothelial function in humans. , 2011, Clinical science.

[25]  B. Cho,et al.  Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation , 2010, Transplantation.

[26]  Y. Kodera,et al.  Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy , 2009, Bone Marrow Transplantation.

[27]  C. Alpers,et al.  Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[28]  Thomas M Braun,et al.  A biomarker panel for acute graft-versus-host disease. , 2009, Blood.

[29]  H. Lazarus,et al.  Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? , 2007, Bone Marrow Transplantation.

[30]  J. Moake,et al.  Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. , 2007, Haematologica.

[31]  A. Gratwohl,et al.  Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants , 2005, Bone Marrow Transplantation.

[32]  R. Soiffer,et al.  Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[33]  R. Soiffer,et al.  Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.